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A Mutation in LTBP2 Causes Congenital Glaucoma in Domestic Cats
(Felis Catus)
Abstract

The glaucomas are a group of diseases characterized by optic nerve damage that together represent a leading
cause of blindness in the human population and in domestic animals. Here we report a mutation in LTBP2
that causes primary congenital glaucoma (PCG) in domestic cats. We identified a spontaneous form of PCG
in cats and established a breeding colony segregating for PCG consistent with fully penetrant, autosomal
recessive inheritance of the trait. Elevated intraocular pressure, globe enlargement and elongated ciliary
processes were consistently observed in all affected cats by 8 weeks of age. Varying degrees of optic nerve
damage resulted by 6 months of age. Although subtle lens zonular instability was a common feature in this
cohort, pronounced ectopia lentis was identified in less than 10% of cats examined. Thus, glaucoma in this
pedigree is attributed to histologically confirmed arrest in the early post-natal development of the aqueous
humor outflow pathways in the anterior segment of the eyes of affected animals. Using a candidate gene
approach, significant linkage was established on cat chromosome B3 (LOD 18.38, θ = 0.00) using tightly
linked short tandem repeat (STR) loci to the candidate gene, LTBP2. A 4 base-pair insertion was identified in
exon 8 of LTBP2 in affected individuals that generates a frame shift that completely alters the downstream
open reading frame and eliminates functional domains. Thus, we describe the first spontaneous and highly
penetrant non-rodent model of PCG identifying a valuable animal model for primary glaucoma that closely
resembles the human disease, providing valuable insights into mechanisms underlying the disease and a
valuable animal model for testing therapies.
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Abstract
The glaucomas are a group of diseases characterized by optic nerve damage that together
represent a leading cause of blindness in the human population and in domestic animals.
Here we report a mutation in LTBP2 that causes primary congenital glaucoma (PCG) in
domestic cats. We identified a spontaneous form of PCG in cats and established a breeding
colony segregating for PCG consistent with fully penetrant, autosomal recessive inheritance
of the trait. Elevated intraocular pressure, globe enlargement and elongated ciliary processes were consistently observed in all affected cats by 8 weeks of age. Varying degrees
of optic nerve damage resulted by 6 months of age. Although subtle lens zonular instability
was a common feature in this cohort, pronounced ectopia lentis was identified in less than
10% of cats examined. Thus, glaucoma in this pedigree is attributed to histologically confirmed arrest in the early post-natal development of the aqueous humor outflow pathways in
the anterior segment of the eyes of affected animals. Using a candidate gene approach, significant linkage was established on cat chromosome B3 (LOD 18.38, θ = 0.00) using tightly
linked short tandem repeat (STR) loci to the candidate gene, LTBP2. A 4 base-pair insertion
was identified in exon 8 of LTBP2 in affected individuals that generates a frame shift that
completely alters the downstream open reading frame and eliminates functional domains.
Thus, we describe the first spontaneous and highly penetrant non-rodent model of PCG
identifying a valuable animal model for primary glaucoma that closely resembles the human
disease, providing valuable insights into mechanisms underlying the disease and a valuable animal model for testing therapies.
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Introduction
Glaucoma is a leading cause of blindness due to characteristic damage to the retinal ganglion
cells (RGCs) and optic nerve, and in the human population is estimated to affect more than 60
million people worldwide [1]. Maintenance of an intraocular pressure (IOP) within a defined
normal range is vital to the structural and physiological well-being of the eye. Aqueous humor
is continuously produced by the ciliary body epithelium and is drained from the anterior
chamber of the eye to the systemic circulation, primarily through the trabecular meshwork
and Schlemm’s canal located just anterior to the root of the iris. The IOP is the result of the
dynamic relationship between aqueous humor production and outflow. Obstruction of aqueous humor outflow leads to elevated IOP, which is an important risk factor for the development of glaucoma [2].
Although glaucoma is generally considered a disease of older adults, it is an important and
devastating cause of vision loss in children, accounting for just under 7% of cases of childhood
blindness worldwide [3–5]. A number of chromosomal loci associated with primary congenital
glaucoma (PCG) have been identified in humans (OMIM 231300, 600975, 613085, and
613086) and mutations in the cytochrome P450 gene, CYP1B1, and LTBP2 gene at two of these
loci were identified in families segregating PCG [6, 7].
However, despite advances in our knowledge of glaucoma genetics, basic research in the
pathogenesis and treatment of glaucoma in general, and PCG in particular, has been hampered
by a lack of appropriate animal models [8]. Spontaneous glaucoma has been reported in a
number of species including dogs and cats [9, 10] and an underlying molecular genetic basis
reported for open angle glaucoma in Beagles [11]and Norwegian elkhounds [12] and angle closure glaucoma in Basset hounds [13]. We have established and characterized a novel, spontaneous, feline model of PCG. The phenotype was initially observed in a pair of Siamese cats but, as
reported previously and demonstrated here, is independent of the Siamese genetic background
[14]. Here we report the causal mutation in LTBP2, a known gene implicated in human PCG
(OMIM 613086) [7, 15]. This represents the first extant, large animal model of PCG and is the
first report documenting a causal mutation for glaucoma in cats.

Results
Clinical phenotype of feline PCG
Clinical examination to determine ocular phenotype was conducted in 147 cats in an expanded
pedigree. Apart from the ocular phenotypes, the proband siblings and the two founding individuals appeared to be healthy, with no overt systemic abnormalities and were fertile. Neonatal
mortality and incidence of other congenital abnormalities, such as cleft palate or cardiac defects
was comparable to, or lower than, reported for purebred cats in other establishments and the
general feline population. A distinctive, abnormal ocular phenotype was identified in all offspring that resulted from matings between these two Siamese individuals, and from other
affected to affected pairings in the pedigree. All affected cats have bilateral mild to moderate
globe enlargement that is generally apparent as soon as eye examinations can be reliably carried
out in kittens. The disease is typically bilateral and symmetrical and no significant differences
between the left and right eyes were observed. By the age of 8 weeks mean IOP is significantly
higher in cats with congenital glaucoma than in normal cats (Fig 1). With the exception of
<2% of animals examined that had grossly enlarged globes and corneal edema, all affected cats
were subjectively assessed to be visual. Neither episcleral vascular congestion nor signs suggestive of ocular pain were apparent or attributable to the glaucoma phenotype and there was no
evidence of intraocular inflammation on slit-lamp biomicrosopy.
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Fig 1. Intraocular pressure in glaucomatous and normal cats. Intraocular pressure measured by rebound
tonometry (TonoVet, ICare oy, Finland) was significantly greater in PCG (solid bars) than in normal cats
(patterned bars) at all ages from 2 months of age (ANOVA with Tukey-Kramer multiple comparisons posttest, p<0.05). Error bars represent standard deviation. Numbers (n) of subjects in each age group are
indicated on each column.
doi:10.1371/journal.pone.0154412.g001

Gonioscopy revealed open or slightly narrowed iridocorneal angles, with subtle dysplasia
of the pectinate ligament that is normally characterized by sparse and delicate fibers that span
the entrance to the ciliary cleft in cats (Fig 2). This feature is consistent with goniodysgenesis,
supported by the extreme narrowing of the ciliary cleft reported previously on high resolution
ultrasonography of the ocular anterior segment in affected animals [16]. Additional clinical
features noted in affected animals include prominent, elongated ciliary processes, spherophakia, iris hypoplasia (Fig 3) and iridodonesis (iris trembling). These features are readily and
consistently observed in cats over 4 months of age, but are not consistently appreciable in
younger kittens. More pronounced clinical signs of lens instability, i.e. anterior or posterior
lens subluxation and luxation (ectopia lentis) occur within the first two years of life in ~8% of
affected eyes. Haab’s striae (a feature of corneal stretching) or corneal edema are observed in
fewer than 10% of affected eyes. When present, corneal edema is generally associated with
lens instability and corneal endothelial contact by an anterior luxated or subluxated lens.
Mild to pronounced optic nerve head cupping can be appreciated on ophthalmoscopy in all
affected cats from 6 months of age (Fig 4) and is consistent with histopathological findings
(see below).
To characterize the morphologic abnormalities in the aqueous outflow pathway, sagittal histologic sections of enucleated eyes were evaluated by light microscopy. Eyes were obtained
from 16 affected and 20 age-matched F1 out-crossed and unrelated control cats humanely
euthanized from one day to 3 weeks of age. In the anterior segment a paucity of intra-scleral
blood vessels, and hypoplasia of iris stroma and ciliary body, is evident at birth in affected
cats (Fig 5). Elongation of the ciliary processes is a consistent finding in affected cats by 3
weeks of age. Post-natal development of the structures of the ciliary cleft, which should be well
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Fig 2. Gonioscopic Features of Feline Primary Congenital Glaucoma. Goniophotograph illustrates an
open, but slightly narrowed, iridocorneal angle (opening of ciliary cleft; indicated by arrow heads) and mild
dysplasia of the pectinate ligament visualized by gonioscopy in a 7 month-old Siamese cat with primary
congenital glaucoma. No ectopia lentis was evident in this subject. (I = Iris, P = pupil, Art. C = major arterial
circle of iris).
doi:10.1371/journal.pone.0154412.g002

Fig 3. Clinical Appearance of Feline Primary Congenital Glaucoma. Iris hypoplasia and ectopia lentis in
feline PCG. The outline of the posteriorly subluxated lens can be readily appreciated through thin, translucent
iris tissue in this affected Siamese cat.
doi:10.1371/journal.pone.0154412.g003
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Fig 4. Optic Nerve Head Cupping in Feline Primary Congenital Glaucoma. Fundus photographs illustrate
the cupped and degenerate optic nerve head of [A] a cat with advanced primary congenital glaucoma and
compared with a normal age-matched cat [B]. An optic nerve cube scan obtained by spectral domain optical
coherence tomography (OCT;Cirrus, Carl Zeiss Meditec Inc., Dublin, CA) acquired in this affected cat
confirms dramatic posterior displacement of the lamina cribrosa (LC, arrowed)[C] compared to the normal
control[D]. (Modified, with permission, from McLellan GJ, Rasmussen CA. Optical coherence tomography for
the evaluation of retinal and optic nerve morphology in animal subjects: practical considerations. Veterinary
Ophthalmology. Sep 2012;15 Suppl 2:13–28.).
doi:10.1371/journal.pone.0154412.g004

developed by three weeks of age in normal cats, [17] appears to be arrested in affected kittens.
The uveal and corneo-scleral trabecular meshwork, angular aqueous plexus (analogous to
Schlemm’s canal in human eyes), and associated vascular channels are rudimentary in affected
animals and when visible, appear collapsed.

Fig 5. Arrested development of Aqueous Humor Outflow Pathways in Feline Primary Congenital
Glaucoma. Photomicrographs of the iridocorneal angle in one day old (A and B) and 18 day old (C and D)
cats. Affected cats (A and C) from the pedigree appear to develop fewer scleral vessels (asterisk) than
normal and F1 out-crossed animals (B and D). Affected animals also fail to develop the normal vessels of the
angular aqueous plexus (analogous to the canal of Schlemm in humans), collector channels and intrascleral
venous plexus (arrowheads).
doi:10.1371/journal.pone.0154412.g005
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Fig 6. Retinal Ganglion Cell Loss in Cats With Primary Congenital Glaucoma. Photomicrographs
showing representative optic nerve sections [A-D], stained with p-phenylenediamine to highlight axonal
myelin sheaths, from 2 young adult cats. [A,C] normal cat (estimated 83,398 optic nerve axons); [B,D] typical
PCG-affected cat with moderate degree of axon loss (estimated 30,365 optic nerve axons). Mid-peripheral
retina in cresyl violet stained retinal whole mounts from these same two cats show relative loss of Nisslstained retinal ganglion cell (RGC) somas of >12μm diameter in the ganglion cell layer of the retina in PCG
(total RGC soma count in whole retina of 43,891)[E] relative to a normal cat [F] (estimated RGC soma count
in whole retina of 123,833). Bar markers = 200μm (top row); 20μm (middle row), and 12μm (bottom row).
doi:10.1371/journal.pone.0154412.g006

Histological examination of optic nerve specimens derived from 66 eyes of 38 glaucomatous
cats and 33 eyes of 20 normal cats that were 6 months of age or older confirmed that optic
nerve head cupping observed clinically is accompanied by significant reduction in the number
of optic nerve axons (Figs 6 and 7), consistent with a prior report of structural and functional
abnormalities of the inner retina and optic nerve that were identified in vivo by optical coherence tomography and electrophysiology, respectively [18].
No significant outer retinal pathology is observed in the majority of cats with PCG (Fig 8).
Thickness of the outer retinal layers is not significantly different from normal in young adult
PCG cats (p>0.05, student t-test), except in those animals with severe disease and near total
loss of retinal ganglion cell axons and somas.
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Fig 7. Optic Neuropathy in Feline Primary Congenital Glaucoma. Mean axon count in PCG cats (66 eyes
of 38 cats aged 4 months to 8 years) is significantly lower (44,438 ± 2,272 [SEM]) than in normal cats
(mean = 70,510 ± 1,535 in 33 eyes of 20 normal cats; p<0.0001, unpaired t-test). Lines represent mean and
error bars represent SD.
doi:10.1371/journal.pone.0154412.g007

Inheritance pattern of feline PCG
In order to determine the inheritance pattern of PCG in this pedigree of cats we established a
breeding colony and created an expanded, informative pedigree (Fig 9). Beginning with the

Fig 8. Preservation of Normal Outer Retinal Structure in Feline Primary Congenital Glaucoma.
Representative fluorescence photomicrographs of DAPI stained 18 month old glaucomatous [A] and normal
6 month old [B] feline retinas. No significant difference in morphology of outer retinal layers is identified.
(GCL = ganglion cell layer; IPL = inner plexiform layer; INL = inner nuclear layer; OPL = outer plexiform layer;
ONL = outer nuclear layer; RPE = retinal pigment epithelium).
doi:10.1371/journal.pone.0154412.g008
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Fig 9. Feline congenital glaucoma pedigree. Additional pairings between affected and affected animals
consistently produced all affected offspring but are not depicted in this informative pedigree. Females are
depicted by circles and males by squares, diamonds indicate gender not recorded. Black shapes indicate that
PCG phenotype confirmed by clinical examination conducted by a board certified veterinary ophthalmologist.
Unfilled shapes indicate normal phenotype confirmed on clinical examination. Light gray shading with strikethrough indicates that phenotype was not confirmed. Asterisks indicate those animals from which DNA
samples were obtained and used in linkage analysis and/ or gene sequencing.
doi:10.1371/journal.pone.0154412.g009

two affected Siamese founder cats and two unrelated, outbred domestic shorthaired cats we
have produced over 400 offspring and over 100 litters. Dominant inheritance was excluded by
pairing affected to affected (testing assumptions of heterozygosity for a dominant trait in either
or both parents; p<0.025) and by pairing affected to normal, unrelated cats (p<0.0001). In 14
litters of offspring from carrier (F1) to carrier “intercross” or carrier to affected “backcross”
pairings, the observed frequency of affected kittens is entirely consistent with that expected for
autosomal recessive inheritance (p>0.5). Furthermore, all affected to affected pairings yielded
only affected cats. Hence we conclude that the trait is fully penetrant and autosomal recessive.
Studies in mice have indicated that the ocular phenotype induced by disruption of the
CYP1B1 gene is considerably more pronounced in albino mice [19]. In order to evaluate
whether the inheritance and phenotype of feline PCG could be dependent upon the Siamese
genetic background (i.e. homozygosity for the TYR-G301R mutation responsible for the Siamese coat color phenotype, associated with ocular pigment dilution and blue irides) [20] [21],
normal, domestic short-haired cats were bred to affected Siamese cats. Inter-crosses between
clinically normal F1 out-crossed cats resulted in offspring with normal pigmentation and the
glaucomatous phenotype. In these individuals the glaucomatous phenotype does not appear to
differ in any way from that observed in Siamese cats, suggesting that this trait is independent of

PLOS ONE | DOI:10.1371/journal.pone.0154412 May 5, 2016
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mutation in the TYR gene. Furthermore, the pairing of an affected Siamese founder with an
unrelated, clinically normal Siamese cat yielded clinically normal Siamese offspring.

Linkage Analysis
Using a subset of the animals we subsequently evaluated whether short tandem repeat (STR)
markers tightly linked to candidate genes previously associated with glaucoma or anterior segment dysgenesis in humans exhibited linkage disequilibrium in the pedigree including MYOC,
FOXC1, CYP1B1, PITX2, OPTN, SH3PXD2B, PAX6, and LTBP2. Only STR markers tightly
linked with the LTBP2 locus on feline chromosome B3 yielded results consistent with linkage.
Consequently we examined this locus in greater detail using a total of 16 STR markers located
within and flanking the LTBP2 locus in the extended pedigree (Table 1). Significant linkages
were established with an STR in the predicted 11th intron of LTBP2 (LOD 18.38, θ = 0.00), and
with three additional STRs within LTBP2 (LOD 8.3–17.2, –5.6, θ = 0.00) (Table 1). Several
STRs in flanking regions both 3’ and 5’ of the gene (Table 1) exhibited significant linkage with
PCG, generally displaying decreasing LOD scores with increased distance from the gene
(Table 1). These findings strongly implicate a PCG disease-causing locus located within the
LTBP2 gene on feline chromosome B3.
Oligonucleotide primers flanking all exons of the feline LTBP2 gene were then used to PCR
amplify the entire coding region of this gene in several clinically affected and unaffected animals. Sequencing of these fragments revealed a 4-bp insertion in exon 8 located at chrB3:
120995236 (Fig 10). All examined affected animals (N = 14) were found to be homozygous
whereas unaffected cats (N = 8) are either homozygous or heterozygous for the wild-type
LTBP2 sequence. Additionally, we detected three single nucleotide polymorphisms (SNPs)
located at chrB3:120953711(G->C), chrB3:120974293 (C->T), and chrB3:120999159 (T->C)
(FelCat5). In affected animals these SNPs appear to be in complete linkage disequilibrium
with the insertion, however the last SNP is likely an unrelated polymorphism since it is also
observed in some unaffected and unrelated cats. Furthermore, none of the SNPs results in a
Table 1. Linkage Mapping of the Domestic Cat LTBP2 Locus.
Primer Name

LOD

Theta

Position (Mb)*Cat chrB3

FCA391

1.7041

0.30

PS104

2.6909

0.30

65,738,369–65,738,614
103,122,602–103,122,815

PS110-2

5.4301

0.20

108,579,828–108,580,028

B3-110-1

5.3902

0.20

109,240,802–109,241,001

B3-118-1

6.1280

0.20

116,661,199–116,661,389

LTBP2_L2

8.2975

0.00

120,902,706–120,902,935

LTBP2-L1

14.6794

0.01

120,934,431–120,934,679

LTBP2-L5

18.3823

0.00

120,960,163–120,960,388

LTBP2-L4

17.1825

0.00

120,985,884–120,985,684

5.0796

0.20

122,720,591–122,720,776

PS126
PS130

6.2740

0.20

126,293,720–126,293,960

FCA88

5.8921

0.10

128,694,162–128,694,412

PS132

5.3587

0.10

128,203,904–128,204,079

PS134

5.4575

0.20

130,222,596–130,222,844

PS136

1.6201

0.20

132,098,251–132,098,494

* Markers are shown in genomic order along feline chromosome B3 based on the cat genome assembly version felCat5
doi:10.1371/journal.pone.0154412.t001
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Fig 10. Sequences of Exon 8 of LTBP2 in Normal Cat and in Primary Congenital Glaucoma. Sanger sequencing results of exon 8 of LTBP2 in a
normal (top) and a PCG-affected (bottom) individual. Analysis reveals a 4bp insertion in all affected individuals (boxed). Coordinates are for chromosome
B3 from the felCat5 genome build.
doi:10.1371/journal.pone.0154412.g010

non-synonymous mutation and consequently it is unlikely that these changes result in the
observed phenotype in affected cats.
The LTBP2 mutation was not identified in archived DNA samples from 148 unaffected cats.
This archive included 68 unrelated Siamese cats and 80 other cats representing 31 cat breeds,
as previously reported [22, 23].

LTBP2 is transcribed in the eye of both normal and PCG-affected cats
In order to confirm the predicted mRNA sequence of feline LTBP2 and to determine the transcriptional consequences of this mutation we carried out whole transcriptome shotgun
sequencing (RNAseq) of mRNA isolated from the iridocorneal angle of a young, PCG- affected
cat and an age matched, unrelated healthy control cat. These data were analyzed to determine
if multiple isoforms of the Latent Transforming Growth Factor-β Binding Protein 2 (LTBP2)
exist and if transcripts for LTBP2 can be detected in the anterior segment of affected animals.
The normal cat LTBP2 sequence (S1 Fig) contains 11,523 nucleotides and encodes a protein
of 1,823 amino acids with a predicted molecular weight of 195 kDa (GenBank accession number KT625609). The first 35 amino acids are likely removed during processing of the protein
resulting in a molecular weight of 192.1 kDa [24]. The normal protein contains 13 Epidermal
growth factor (EGF)-like domains as well as 3 Transforming Growth Factor (TGF)-binding
domains, as predicted by the NCBI Conserved domain algorithm (http://www.ncbi.nlm.nih.
gov/Structure/cdd/wrpsb.cgi) [25].
Phylogenetically the feline LTBP2 protein is most closely related to that of other members
of the order Carnivora such as the dog and ferret (94% and 92% identity over 100% length,
respectively). The sequence homology to the human orthologue is 87% over 100% length and
sequence conservation is slightly lower in mice (77% over 98% length) (S2 Fig).
The four bp insertion mutation detected in affected animals results in a frameshift mutation
after nt 2002 of the cDNA sequence. Consequently the mutation induces a frameshift and a
faulty amino acid sequence after residue 486 (S1 Fig). This aberrant sequence incorporates a
further 114 incorrect amino acids before encountering a stop codon and being terminated. The
mutated protein has a predicted molecular weight of 63.7 kDa and, if it is in fact translated,
would lack all functional domains observed in the normal LTBP2 gene product. (Fig 11)
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Fig 11. Predicted Effects of Mutation on Feline LTBP2. Schematic representation of the feline LTBP2 protein in normal (top) and
affected cats (bottom). The sequence contains an amino terminal signal sequence (dark rectangle), 13 EGF-like calcium binding
domains (green) and 3 TGF binding domains (blue). The insertion site causing a frameshift mutation in affected animals is marked by a
vertical bar and the altered sequence caused by the frameshift is indicated by a hatched box.
doi:10.1371/journal.pone.0154412.g011

Transcriptional analysis suggested that there is only one major LTBP2 transcript in the
anterior segment of cat eyes (GEO accession number GSE73263; http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE73263). While we cannot conclusively rule out the existence of
splicing isoforms, our data indicate that these would be quite rare. LTBP2 mRNA was abundant in the tissue samples obtained from an affected cat and no evidence of skipped exons,
incompletely removed intronic sequences, or preferential mRNA degradation was evident
when compared to a healthy control (Fig 12).

Discussion
In this manuscript we present linkage data and molecular genetics that identify a mutation
associated with congenital glaucoma in a novel, spontaneous feline model of PCG. Affected
cats exhibit elevated IOP early in life, globe enlargement, eventual optic nerve head cupping

Fig 12. Coverage across Feline LTBP2 exons by RNA-Seq. RNA-Seq read coverage across the LTBP2 exons within the cat genome.
Coordinates are shown in genomic orientation. The numeric range in the top left indicates the minimum and maximum number of reads
(FPKM-Fragments Per Kilobase of exon per Million) per base for the sample.
doi:10.1371/journal.pone.0154412.g012
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and axon loss, and other clinical and pathological features consistent with glaucoma. Breeding
studies demonstrated an autosomal recessive mode of inheritance for feline PCG, as has been
reported for familial congenital glaucoma in humans, which has greatest prevalence in populations with high rates of consanguinity [26]. The relatedness of our affected Siamese founder
animals was not determined, although they were reportedly obtained from the same breeder.
Congenital glaucoma is rare in cats, although sporadic cases of congenital and goniodysgenetic glaucomas in Siamese, Persian, and domestic short-haired cats have been documented
[10, 27–29]. There are no previous published reports of congenital glaucoma associated with
spherophakia in Siamese cats. However, case descriptions have been published in the veterinary literature involving young Siamese cats with micro-spherophakia, in which IOP and optic
nerve head appearance are not reported and these case reports from the USA and Europe
appear to share many clinical features with the PCG-affected cats in our cohort [30, 31]. Thus,
it is conceivable that the mutation responsible for this recessively inherited disease may have a
wide geographic distribution within the Siamese breed and could be responsible for apparent
predilection for glaucoma in this breed [32, 33]. Although the mutation was not detected in a
preliminary screen of 148 archived DNA samples at the NCI’s Laboratory of Genomic Diversity that represented 32 breeds, including 68 Siamese cat samples, additional screening of the
Siamese cat population for the disease causing mutation warrants consideration, in order to
establish prevalence of this genetic condition within the breed and guide breeding practices to
avoid the glaucoma phenotype.
One of the defining features of Siamese cats is their characteristic coat color which is caused
by a TYR-G301R tyrosinase mutation in their genetic background [21]. Tyrosinase deficiency
has been reported to increase the severity of developmental abnormalities of the aqueous outflow pathways in albino cyp1b1 knockout mice [19]. We therefore considered it possible that
severity of ocular phenotype was modified by ocular pigment dilution in our founding Siamese
cohort. However, by out-crossing to domestic short-haired cats with conventional coat colors
and subsequent back-crosses, we were able to reproduce an identical ocular phenotype in normally pigmented cats [14]. Consequently it appears that the disease causing mutation is highly
penetrant and is not modified by tyrosinase deficiency or other factors in the Siamese cat
genetic background.
Our breeding studies generated an informative pedigree that, coupled with advances in the
feline genome project, identified significant linkage to the gene LTBP2 on feline chromosome
B3, and subsequent sequence analysis identified a 4-bp insertion in exon 8, introducing a
frameshift and truncation of the protein which is likely causal for PCG in this pedigree. This
finding is of particular importance since mutations in LTBP2 have also been implicated in
human congenital glaucoma [7, 15]. Pathogenic missense mutations have been reported, but
human PCG patients are typically homozygous for insertion or deletion mutations leading to
frameshift and premature truncation. These aberrations have been observed throughout the
length of the LTBP2 gene [7, 15, 34, 35]. Our RNA sequence analysis suggests that mutated
LTBP2 is transcribed and that the mRNA is not removed by nonsense-mediated decay. While
unusual, escape from this control mechanism has been reported in other systems and may be
related to the length of the open reading frame [36, 37]. Consequently, it is likely that mutated
LTBP2 is synthesized in affected cats and possibly also in some human patients. This may lead
to the accumulation of a truncated protein with an aberrant carboxy terminal domain, but it is
also possible that these proteins are not retained within the cell and degraded [38]. These cats
not only further establish a role for LTBP2 as a glaucoma causing gene but also provide a spontaneous animal model allowing further investigation of the pathophysiological mechanisms of
PCG as well as potential treatment approaches.
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LTBP2 shares about 45% amino acid identity to LTBP1 but, unlike other LTBPs, does not
appear to directly bind to latent forms of transforming growth factor β (TGFβ). Rather, it
appears to provide structural support during microfibril assembly in the extracellular matrix
(ECM) [39]. However, altered LTBP2 expression, through its impact on assembly of micofibrils
and ECM composition can also influence the bioavailability of TGFβ [40, 41], which is known
to play a complex and important role in glaucoma pathogenesis [42–47]. The spectrum of clinical disease associated with mutations in LTBP2 is rather broad and includes megalocornea,
microspherophakia and ectopia lentis [34, 48, 49], as well as congenital glaucoma [7, 15, 35]. A
role has also been proposed for LTBP2 mutations in adult onset open angle glaucomas [50].
Generalized ECM abnormalities resembling Marfan disease and Weill-Marchesani syndrome
have been observed [34, 35, 51] Further, LTBP2 has been identified as a potential candidate
biomarker for fracture risk [52], death associated with pulmonary disease with acute dyspnea
[53] and adverse renal events in humans [54]. No clinical signs consistent with Weill-Marchesani syndrome, such as short stature, or of Marfan syndrome, such as tall stature, pes excavatum or aortic aneurysm, have been identified on either clinical or pathological examination in
any cats within this colony. Thus, the disease phenotype appears to be largely confined to ocular disease in affected cats. However, longer-term, detailed clinical and histopathologic evaluation of systemic phenotype is ongoing.
It is noteworthy that findings in this cat model differ from those described in knock-out
mice. Early embryonic lethality was previously ascribed to ltbp2 deletion in mice [55], but this
finding was not duplicated in a more recent study [38]. In our colony, LTBP2 mutant cats are
as fertile as control animals and the resulting offspring appear healthy apart from the ocular
phenotype. Thus our studies do not indicate that lack of LTBP2 is lethal. Furthermore, studies
of Inoue, et al. [38], using ltbp2 null mice, provided strong experimental support for a role of
this protein in ciliary zonule microfibril assembly, a role that derives further support from our
observation of lens zonular instability in affected cats in our pedigree. However, the conditional
knockout mice demonstrated consistent lens luxation, which is relatively infrequent among
affected animals in our feline colony. Finally glaucoma was not identified and pronounced
abnormalities in the aqueous outflow pathways were not apparent in the mouse model [38].
The reason for these differences among models is not known but could be related to the nature
of the mutation. Specifically, it is conceivable that affected cats synthesize a truncated LTBP2
that retains some functionality that is lost in knock-out mice. Additionally, species differences
related to structure of the eye and longevity may be a reason for the observed disparities.
The extremely high prevalence of glaucoma and the developmental abnormalities we identified in the aqueous outflow pathways of affected cats strongly suggest that caution should be
exercised in attributing glaucoma pathogenesis in patients with LTBP2 mutations solely to lens
instability, particularly as phenotypic heterogeneity has been described in human patients,
even between individuals with the same mutation in LTBP2 [35]. Thus, genotype may not be
fully predictive of phenotype in families harboring LTBP2 mutations and both primary and
secondary glaucoma may occur. As the surgical management of primary congenital glaucoma
and lens-associated glaucomas are very different, phenotypic heterogeneity observed in human
families and among affected cats in our large pedigree underscores a need for individualized
treatment planning in patients with pathogenic LTBP2 mutations.

Materials and Methods
Animals
All animal studies were carried out in adherence with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and in strict accordance with the recommendations in
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the Guide for the Care and Use of Laboratory Animals of the National Research Council and the
National Institutes of Health. All studies were approved by the Iowa State University and University of Wisconsin-Madison Institutional Animal Care and Use Committees. Cats were housed
and managed in a laboratory animal facility under controlled environmental conditions with 12
hour light cycles, in social groups of 2–15 cats provided with appropriate enrichment. Cats were
fed high quality, commercially available feline dry diets appropriate to their life stage and health
status. The colony was founded as described [14], by two glaucomatous Siamese cats and their
glaucomatous offspring. Outcrosses were obtained, pairing glaucomatous cats with two normal
domestic shorthaired cats and a normal Siamese cat. Disease status was determined as described
below, by clinical evaluation in conscious, lightly restrained cats. Mortality rates in this study
were much lower than in the feline population at large, and as a result necropsy was not routinely
conducted. In addition to neonatal mortalities, rare animals met designated endpoints established for pain, discomfort and illness, as a result of illnesses and injuries unrelated to the glaucoma phenotype. Animals meeting these criteria were euthanized at the clinical discretion of the
Institutions’ veterinary staff. Humane endpoints included failure to thrive, progressive weight
loss not alleviated by supplemental feeding, or occasional non—ocular congenital defects.

Clinical evaluation
All 147 animals surviving to 6 weeks or older were evaluated by a board certified veterinary
ophthalmologist by slit-lamp biomicroscopy (SL14, Kowa, Japan); IOP measurement by applanation tonometry (Tono-pen XL, Medtronic, Jacksonville, FL) following the application of
0.5% proparacaine (Akorn Inc., Lake Forest, IL), or rebound tonometry (TonoVet, ICare oy,
Finland) [56]; direct ophthalmoscopy (Welch Allyn Inc., Skaneateles Falls, NY), and indirect
ophthalmoscopy (Keeler, Broomall, PA) following topical administration of 0.5% tropicamide
(Bausch and Lomb, Inc., Tampa, FL, USA).

Histopathology
Anterior segment development. Eyes were obtained immediately following humane
euthanasia by intravenous administration of barbiturate overdose, from 16 homozygous,
affected cats; 12 out-crossed F1 cats, and 8 age-matched domestic short-haired control cats
ranging in age from 1 to 70 days. Eyes were fixed immediately in 4% paraformaldehyde,
embedded in paraffin, sectioned to a thickness of 5 μm, and stained with Periodic acid-Schiff
(PAS) or hematoxylin / eosin then examined by light microscopy.
Evaluation of optic nerves and retinas. To validate our clinical findings, optic nerve tissues
were also obtained from eyes of 58 cats ranging in age from 4 months to 8 years that were perfusion or drop-fixed with 4% paraformaldehyde, immediately following euthanasia as described
above, over the course of a 10 year period, for various reasons not directly related to the current
study. Optic nerves were post-fixed with glutaraldehyde, resin embedded, osmicated, semi-thin
sectioned and stained with Richardson’s stain or p-phenylenediamine (PPD). Axons were quantified in PPD stained sections using a semi-automated targeted method as previously described
[57]. Whole retinas from 2 normal and 6 PCG cats were mounted on gelatin coated slides and
Nissl-stained with cresyl violet for identification of RGCs (distinguished from glia and displaced
amacrine cells based on morphologic criteria) and manual counting by light microscopy [58, 59].
Thicknesses of the outer retinal layers in DAPI stained sagittal cryosections of peri-papillary retina from 3 normal and 5 young adult PCG cats were measured in fluorescence photomicrographs
using commercially available image analysis software (AxioVision 4.8, Carl Zeiss Microscopy).
Breeding studies. The colony was founded by two glaucomatous Siamese cats and their
glaucomatous offspring. Outcrosses were obtained by pairings with normal domestic shorthaired
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laboratory cats. Disease status was determined by clinical evaluation, as described below. Disease
status was determined in 25 F1 out-crossed cats; in 30 F1 back-crossed cats, and in total over 60
PCG-affected cats were evaluated. Dominant inheritance was assessed by Chi-squared analysis
for goodness of fit of 4 pairings, involving 3 affected Siamese cats and 2 clinically normal, unrelated domestic short-haired cats. In order to evaluate whether the inheritance of feline congenital
glaucoma could be dominant on a Siamese genetic background, i.e. homozygosity for the
TYR-G301R mutation responsible for the Siamese coat color phenotype [21], a normal, unrelated
Siamese female was bred to an affected Siamese male. Recessive inheritance was examined by
Chi-squared analysis of seven back-crosses, pairing clinically normal F1 out-crossed females
with clinically affected Siamese males; and five pairings of F1 out-crossed males and females.

Candidate Gene and Linkage Analysis
For molecular genetic studies, DNA was routinely isolated from feline blood or tissue samples
according to manufacturer’s protocols using the QIAampDNA Mini Kit (Qiagen; http://www.
quiagen.com). DNA was quantified using the NanoDrop spectrophotometric method (http://
www.nanodrop.com).
Linkage analysis of candidate loci was carried out using short tandem repeat markers
(STRs) to genotype an informative subset of the larger PCG pedigree (S1 Table). Candidate
genes included 8 genes previously associated with congenital or other heritable forms of glaucoma, or ocular anomalies in humans (MYOC [56], FOXC1 [60, 61], CYP1B1 [6], PITX2 [62],
OPTN [63], SH3PXD2B [64], LTBP2 [7], and PAX6 [65]). DNA samples were quantified,
inspected on a gel, and genotyped using a forensic panel, the MEOWPLEX [22], to verify pedigree structure and confirm Mendelian inheritance. Linkage analysis computations were performed with SUPERLINK (http://bioinfo.cs.technion.ac.il/superlink-online/) using a fully
penetrant, autosomal disease model with a disease allele frequency of 0.01. Marker allele frequencies were set as equal. Primers were designed tightly linked to the 8 listed candidate genes
using the cat genomic browser GARField [66]. Primers were tested to determine informativeness of the STRs and for yield of expected amplicon length (S1 Table). Amplification of the
STRs was performed by a touchdown PCR reaction protocol as described [22]. PCR products
were fluorescently labeled using M13 tailed primers as described [67]. Products were analyzed
on an Applied Biosystems Model 3100 genetic analyzer with Genescan version 3.7 and Genotyper version 2.5 software (http://www.appliedbiosystems.com).
The feline LTBP2 mRNA sequence was deduced by BLAST alignment of the respective
human cDNA sequence to the feline genome (felCat4). Portions of the exons not represented
in the database were isolated by one-sided PCR, cloned and sequenced. Sequence information
was used to design PCR primer pairs that allowed the amplification of all exons of the gene (S1
Table). Following amplification, the genomic sequences from affected and unaffected animals
were determined by Sanger sequence analysis and evaluated for the presence of sequence variations indicative of an involvement of the candidate gene in the development of the phenotype.
LTBP2 transcriptional analysis. Total RNA was extracted from the iridocorneal angle
and ciliary body, including the adjacent sclera and trabecular meshwork of an affected 2
month-old cat and an unrelated, age-matched healthy control. After confirmation of RNA
integrity both samples were transcriptionally profiled using the HiSeq sequencing system
(Illumina, San Diego, CA, http://www.illumina.com). The resulting sequence reads
were aligned to Felis catus genome build felCat5 using Tophat software (ver. 2.0.9 http://ccb.
jhu.edu/software/tophat/index.shtml) [68]. Run parameters were: Tophat (ver. 2.0.9)
(—max-insertion-length 4,—read-mismatches 2,—read-gap-length 4,—read-edit-dist 4, -G
with Ensembl gene predictions)
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Transcript abundance and differential expression were calculated using the software Cufflinks (ver. 2.1.1; http://cufflinks.cbcb.umd.edu/)[68], and cummeRbund (ver. 2.4.1; http://
compbio.mit.edu/cummeRbund/)[69]. Analysis parameters for Cufflinks were (—max-bundle-frags 20000000).
To generate cDNA sequences, exon coordinates for each isoform identified were exported
from cummeRbund. Consensus variants within these regions were called using samtools mpileup (ver. 0.1.18) and bcftools (ver. 0.1.17-dev)[70]. This produces a single variant call at each
position based on the most common allele observed in the RNA-Seq reads. Variants with
QUAL value  100 and exon coordinates were passed on to GATK FastaAlternateReferenceMaker (ver. 2.5-2-gf57256b) to produce mRNA sequences. Short regions that remained unresolved in felCat5 were bridged by manual incremental alignments of unmapped sequence
reads to the obtained consensus sequence.
cDNA sequence translations to amino acid sequences were carried out using ExPASy
(http://www.expasy.org) tools and protein domains were mapped using the NCBI conserved
domains server (http://www.ncbi.nlm.nih.gov/cdd/). Sequences with substantial open reading
frames were aligned using the Clustal Omega implementation at Uniprot (http://www.ebi.ac.
uk/Tools/msa/clustalo/)[71].

Supporting Information
S1 Fig. Complete cDNA and amino acid sequence of feline LTBP2. The initiation codon is
shaded yellow. The 4-bp sequence, which is duplicated in affected animals, is included in the
cDNA sequence and shaded red. Amino acid sequences of healthy (LTBP2) and affected
(affec) animals are included.
(DOCX)
S2 Fig. Sequence homology of feline LTBP2 to the human orthologue is 87% over 100%
length. Sequence homology to human LTBP2 is slightly lower in mice (77% over 98% length).
(DOCX)
S1 Table. Short tandem repeat markers (STRs) used for 7 candidate genes and for LTBP2
in linkage analysis to genotype an informative subset of the larger PCG pedigree. Primers
were tested to determine informativeness of the STRs and for yield of expected amplicon
length. The third tab in this spreadsheet shows PCR primer pairs that enabled the amplification
of all exons of the feline LTBP2 gene.
(XLSX)
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